VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CDLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CDLXCardlytics, Inc.
$4.87$28M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCDLXCash Flow

Cardlytics, Inc. (CDLX) Cash Flow Statement

11Y historyFree accessUpdated daily

Liquidity remains under pressure as free cash flow swung to a negative $5.6M in 2026Q1, further strained by $4.8M in stock-based compensation expenses.

CDLX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15
Cash from Operations10.35M9.29M-8.82M-185K-53.9M-38.52M-7.6M11.46M-19M-22.1M-32.5M-29.16M
Operating CF Margin %-3.98%-3.17%-0.06%-18.06%-14.42%-4.07%5.44%-12.61%-16.95%-28.8%-37.56%
Operating CF Growth %307.49%205.28%-4669.73%99.66%-39.93%-407.01%-166.32%160.32%14.06%31.99%-11.45%-
Net Income-94.69M-103.49M-189.3M-134.7M-465.26M-128.56M-55.42M-17.14M-53.04M-19.64M-75.7M-40.63M
Depreciation & Amortization25.23M27.41M27.88M29.52M43.74M35.65M11.59M4.54M3.28M3.03M4.22M2.19M
Stock-Based Compensation24.26M28.13M40.37M40.98M44.69M50.26M32.4M15.85M26.79M5.15M3.45M2.45M
Deferred Taxes0000-1.45M-7.86M006.76M654K1.13M-189K
Other Non-Cash Items47.56M51.53M128.01M77.5M335.7M18.68M7.59M3.6M644K2.93M48.26M877K
Working Capital Changes7.99M5.71M-15.77M-13.47M-11.32M-6.7M-3.75M4.62M-3.43M-14.22M-13.86M6.13M
Change in Receivables31.42M20.64M12.5M-7.72M-4.55M-27.94M-2.4M-26.02M-9.43M-7.5M-5.79M-5.48M
Change in Inventory000000008.96M1.99M1.37M11.66M
Change in Payables-539K179K499K239K-893K1.26M16K-601K911K-1.91M-1.23M1.97M
Cash from Investing-13.7M-15.3M-18.75M-10.06M-15.76M-506.69M-10.12M-11.02M-7.34M-1.65M-2.54M-6.3M
Capital Expenditures-5.2M-15.78M-1.56M-667K-1.17M-3.11M-5.41M-8.28M-7.34M-1.65M-2.54M-6.3M
CapEx % of Revenue2.53%6.77%0.56%0.22%0.39%1.16%2.89%3.93%4.87%1.26%2.26%8.12%
Acquisitions-200K480K02.33M-2.27M-494.13M000000
Investments------------
Other Investing-8.31M0-17.18M-11.72M-12.31M-9.46M-4.71M-2.74M-1.42M-432K-718K-597K
Cash from Financing-13.11M-11.12M1.44M-20.03M-39.99M486M206.43M44.18M65.19M21.76M30.81M11.93M
Debt Issued (Net)-11.14M-6.12M-26.8M29.97M-35K0223.08M-46.7M-5.15M12.4M33.62M12.02M
Equity Issued (Net)0048.65M55K-39.62M486.39M10.19M91.22M72.33M0279K271K
Dividends Paid000000000000
Share Repurchases0000-40M000000-193K
Other Financing-1.97M-5M-20.4M-50.05M-331K-390K-26.83M-339K-2M9.36M-3.09M-361K
Net Change in Cash-16.37M-16.88M-26.24M-30.16M-111.58M-59.79M188.76M44.72M38.61M-1.71M-4.64M-23.59M
Free Cash Flow1.23M8.81M-28.12M-12.58M-67.39M-51.09M-17.71M437K-26.34M-23.75M-35.04M-35.46M
FCF Margin %0.6%3.78%-10.11%-4.07%-22.57%-19.13%-9.48%0.21%-17.48%-18.22%-31.06%-45.67%
FCF Growth %110.42%131.33%-123.6%81.34%-31.91%-188.38%-4153.78%101.66%-10.9%32.23%1.17%-
FCF per Share0.221.66-5.82-3.45-20.17-15.86-6.510.18-13.82-12.17-24.98-165.83
FCF Conversion (FCF/Net Income)-0.01x-0.09x0.05x0.00x0.12x0.30x0.14x-0.67x0.36x1.13x0.43x0.72x
Interest Paid839K0002.38M2.33M63K1.27M0000
Taxes Paid000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity exhaustion and revenue decline

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Persistent Disconnect Between Earnings Cash

As reported in recent financial filings, the company frequently exhibits a significant divergence between net income and operating cash flow, with the OCF/NI ratio reaching 1.26 in 2026Q1, suggesting that accounting losses are not fully capturing the underlying cash outflows required to sustain current operations.

The recurring gap between net losses and operating cash flow indicates that non-cash expenses, particularly stock-based compensation, are heavily influencing the reported bottom line. Investors should monitor whether this reliance on non-cash adjustments masks a structural inability to generate positive cash flow from core advertising activities.

Free Cash Flow Volatility Persists

Based on the company's reported figures, free cash flow remains highly inconsistent, swinging from a positive $13.0M in 2025Q4 to a negative $5.6M in 2026Q1, which underscores the difficulty in achieving a sustainable, self-funding trajectory amidst ongoing top-line contraction and high fixed operating costs.

The erratic nature of FCF suggests that the business lacks the operational scale to absorb seasonal fluctuations or shifts in advertiser demand. This volatility warrants further investigation into whether the company can reach a breakeven point before its existing cash reserves are fully depleted.

Capital Intensity Remains Relatively Low

According to historical data, the company maintains a modest capital intensity, with CapEx as a percentage of revenue peaking at 7.8% in 2024Q3, suggesting that the primary burden on cash flow is not physical asset replacement but rather the high fixed costs inherent in its software-based model.

While low capital intensity is typically a positive attribute for technology firms, it appears insufficient to offset the persistent operating losses here. The lack of significant investment in tangible assets may imply that the company is prioritizing survival over the long-term development of its data platform.

SBC Masks True Cash Burn

As evidenced by recent financial statements, stock-based compensation remains a substantial non-cash expense, totaling $4.8M in 2026Q1, which effectively obscures the true economic cost of operations and complicates the assessment of the company's actual cash burn relative to its reported net loss of $4.5M.

The consistent use of equity-based compensation appears to be a critical mechanism for preserving cash, yet it creates a persistent dilution risk for shareholders. Analysts should interpret these figures with caution, as the reliance on SBC may be masking a deeper, more structural cash flow deficit that is not immediately apparent in the headline numbers.

CDLX — Frequently Asked Questions

Quick answers to the most common questions about buying CDLX stock.

How much cash does Cardlytics, Inc. (CDLX) generate from operations?

Cardlytics, Inc. (CDLX) generated $9.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Cardlytics, Inc.'s free cash flow?

Cardlytics, Inc. (CDLX) generated $8.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Cardlytics, Inc.'s capital expenditure (CapEx)?

Cardlytics, Inc. (CDLX) spent $15.8M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.